Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

CBIO holding history

Crescent Biopharma, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CBIO overviewAll 13F holders of CBIOFull Q4 2025 holdings

Shares (Q4 2025)
557,506
Value
$6.61M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of CBIO by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 2025557,506$6.61M<0.1%−100,394−15.3%ReducedHolders
Q3 2025657,900$7.82M<0.1%+657,900NewHolders
Q2 20250$00.0%−2,670,208−100.0%Sold outHolders
Q1 20252,670,208$560.7K<0.1%00.0%UnchangedHolders
Q4 20242,670,208$664.9K<0.1%00.0%UnchangedHolders
Q3 20242,670,208$451.3K<0.1%−26,698−1.0%ReducedHolders
Q2 20242,696,906$759.4K<0.1%−65,075−2.4%ReducedHolders
Q1 20242,761,981$8.29M<0.1%+340,112+14.0%AddedHolders
Q4 20232,421,869$5.72M<0.1%00.0%UnchangedHolders
Q3 20232,421,869$3.63M<0.1%+107,464+4.6%AddedHolders
Q2 20232,314,405$4.03M<0.1%−146,428−6.0%ReducedHolders
Q1 20232,460,833$3.10M<0.1%+185,120+8.1%AddedHolders
Q4 20222,275,713$6.90M<0.1%+396,301+21.1%AddedHolders
Q3 20221,879,412$1.04M<0.1%+32,650+1.8%AddedHolders
Q2 20221,846,762$1.10M<0.1%+31,799+1.8%AddedHolders
Q1 20221,814,963$2.07M<0.1%−423,590−18.9%ReducedHolders
Q4 20212,238,553$3.22M<0.1%−21,461−0.9%ReducedHolders
Q3 20212,260,014$4.95M<0.1%−10,443−0.5%ReducedHolders
Q2 20212,270,457$5.27M<0.1%−387,676−14.6%ReducedHolders
Q1 20212,658,133$8.00M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.